HIV-1 p24 derived epitopes modulate KIR2DL2-binding to HLA-Cw03

por van Teijlingen, NH, Körner, C, Fadda, L, Brander, C, Carrington, MN, van Baarle, D, Altfeld, M
Publicado 2012

Effect of latent cytomegalovirus infection on the antibody response to influenza vaccination: a systematic review and meta-analysis

por van den Berg, S. P. H., Warmink, K., Borghans, J. A. M., Knol, M. J., van Baarle, D.
Publicado 2019

Low doses of the novel caspase-inhibitor GS-9450 leads to lower caspase-3 and -8 expression on peripheral CD4+ and CD8+ T-cells

por Arends, J. E., Hoepelman, A. I. M., Nanlohy, N. M., Höppener, F. J. P., Hirsch, K. R., Park, J. G., van Baarle, D.
Publicado 2011

OA06-05. Adaptation of HIV-1 to the human immune system at the population level is driven by protective HLA-B alleles

por Schellens, IM, Navis, M, van Deutekom, HW, Boeser-Nunnink, B, Berkhout, B, Kootstra, N, Miedema, F, Kesmir, C, Schuitemaker, H, van Baarle, D, Borghans, JA
Publicado 2009

Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1

por Oostvogels, R, Minnema, M C, van Elk, M, Spaapen, R M, te Raa, G D, Giovannone, B, Buijs, A, van Baarle, D, Kater, A P, Griffioen, M, Spierings, E, Lokhorst, H M, Mutis, T
Publicado 2013

TTV Load is Associated with SARS-CoV-2 Vaccination Response in Lung Transplant Recipients

por Verschuuren, E.A., Hoek, R., de Vries, R.D., van Baarle, D., van der Heiden, M., van Gemert, J., Gore, E., Niesters, H.G., Erasmus, M.E., Hellemons, M.E., Scherbeijn, S., van Kessel, C.H. Geurts, van Leer Buter, C.
Publicado 2022

LBA8 Vaccination against SARS-CoV-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors

por Oosting, S., Van der Veldt, A.A.M., GeurtsvanKessel, C.H., Fehrmann, R.S.N., van Binnendijk, R.S., Dingemans, A-M.C., Smit, E.F.F., Hiltermann, T.J.N., den Hartog, G., Jalving, M., Westphal, T., Battacharya, A., van der Heiden, M., Blank, C.U., Koopmans, M.P., van Els, C.A., Rots, N.Y., van Baarle, D., Haanen, J.B.A.G., de Vries, E.G.
Publicado 2021

The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women

por Hoenderboom, B. M., van Oeffelen, A. A. M., van Benthem, B. H. B., van Bergen, J. E. A. M., Dukers-Muijrers, N. H. T. M., Götz, H. M., Hoebe, C. J. P. A., Hogewoning, A. A., van der Klis, F. R. M., van Baarle, D., Land, J. A., van der Sande, M. A. B., van Veen, M. G., de Vries, F., Morré, S. A., van den Broek, I. V. F.
Publicado 2017

Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors

por Oosting, S.F., van der Veldt, A.A.M., Fehrmann, R.S.N., Bhattacharya, A., van Binnendijk, R.S., GeurtsvanKessel, C.H., Dingemans, A.-M.C., Smit, E.F., Hiltermann, T.J.N., den Hartog, G., Jalving, M., Westphal, T.T., de Wilt, F., Ernst, S.M., Boerma, A., van Zijl, L., Rimmelzwaan, G.F., Kvistborg, P., van Els, C.A.C.M., Rots, N.Y., van Baarle, D., Haanen, J.B.A.G., de Vries, E.G.E.
Publicado 2023

One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment

por van der Veldt, A.A.M., Oosting, S.F., Fehrmann, R.S.N., GeurtsvanKessel, C.H., van Binnendijk, R.S., Dingemans, A.-M.C., Smit, E.F., Hiltermann, T.J.N., Hartog, G. den, Jalving, M., Westphal, T.T., Bhattacharya, A., de Wilt, F., Ernst, S.M., Boerma, A., van Zijl, L., Rimmelzwaan, G.F., Kvistborg, P., van Els, C.A.C.M., Rots, N.Y., van Baarle, D., Haanen, J.B.A.G., de Vries, E.G.E.
Publicado 2023